Pilot Study on the Validity of the Metacognitive Hub Model of Craving in Bulimia Nervosa (BN) and Binge Eating Disorders (BED)
Launched by LAVAL UNIVERSITY · May 18, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how cravings for food affect women with Bulimia Nervosa and Binge Eating Disorder. Researchers are particularly interested in understanding how different mental systems—like automatic reactions and awareness of feelings—play a role in these cravings. They believe that how well someone understands their own thinking (called metacognition) might influence how strongly they feel these cravings. By looking at how women respond to images of food, the study aims to connect cravings with the challenges faced by those with these eating disorders.
To participate in this study, women aged 18 to 45 who have been diagnosed with either Bulimia Nervosa or Binge Eating Disorder are welcome to join, as long as they speak French and can give their consent. However, those with substance use disorders, or who are pregnant or breastfeeding, cannot take part. Participants will be asked to view food pictures and share their experiences, helping researchers better understand the link between cravings and eating disorders. This study could be an important step in developing better treatments for these conditions.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • have been medically diagnosed with binge eating disorder or bulimia nervosa
- • fluent in french
- • able to consent
- Exclusion Criteria:
- • co-morbid substance use disorder,
- • pregnancy or breastfeeding
About Laval University
Laval University is a prestigious research institution located in Quebec, Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. The university actively engages in clinical trials aimed at exploring new therapeutic interventions and improving patient outcomes. With a strong emphasis on ethical standards and rigorous scientific methodologies, Laval University collaborates with multidisciplinary teams of researchers, healthcare professionals, and industry partners to conduct high-quality clinical research. Its state-of-the-art facilities and dedication to fostering a culture of inquiry position Laval University as a leader in clinical research, contributing significantly to the understanding and treatment of diverse medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Québec, , Canada
Québec, , Canada
Nantes, , France
Patients applied
Trial Officials
Sylvain Iceta, MD, PhD
Principal Investigator
Fondation IUCPQ
Valentin Flaudias, Psy, PhD
Study Chair
Université de Nantes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported